| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | MLN2480 |
|---|
| Description | MLN 2480(BIIB-024) is an oral, selective pan-Raf kinase inhibitor in clinical trials. MW: 506.29. Purity >98% |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | MLN2480; ML-N2480; ML N2480; BIIB-024; BIIB024; BIIB 024; TAK-58; TAK580; TAK 580; AMG 2112819; AMG-2112819; AMG2112819; (R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide; 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
|---|
| Gene, Accession, CAS # | CAS: 1096708-71-2 |
|---|
| Catalog # | B1706-25 |
|---|
| Price | |
|---|
| Order / More Info | MLN2480 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|